2011
DOI: 10.1097/tp.0b013e318215e709
|View full text |Cite
|
Sign up to set email alerts
|

Stool Calprotectin Monitoring After Small Intestine Transplantation

Abstract: Although more frequent prospective sampling could perhaps demonstrate an advantage in early indication of rejection, based on these data, routine stool calprotectin monitoring is not strongly supported.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0
2

Year Published

2014
2014
2018
2018

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 13 publications
0
17
0
2
Order By: Relevance
“…Stool calprotectin has been heralded as a potential biomarker, but it has significant interpatient variability and is unable to differentiate between infection and rejection. 7 Serum citrulline has also been considered, however, it has not been shown to predict asymptomatic rejection and also has significant variability between patients. 8 Immune cell function assay (Cylex ImmuKnow – Viracor IBT Laboratories) has been investigated, and while it may be used as an adjunctive diagnostic tool, it cannot replace endoscopy with biopsy.…”
Section: Discussionmentioning
confidence: 99%
“…Stool calprotectin has been heralded as a potential biomarker, but it has significant interpatient variability and is unable to differentiate between infection and rejection. 7 Serum citrulline has also been considered, however, it has not been shown to predict asymptomatic rejection and also has significant variability between patients. 8 Immune cell function assay (Cylex ImmuKnow – Viracor IBT Laboratories) has been investigated, and while it may be used as an adjunctive diagnostic tool, it cannot replace endoscopy with biopsy.…”
Section: Discussionmentioning
confidence: 99%
“…First, the ITR does not collect detailed perioperative data on donor selection criteria; specific surgical techniques; nutritional management; protocols to detect rejection; and protocols to prevent viral, bacterial and fungal infections (3,14,42,(60)(61)(62)(63). Second, the data provided to the ITR have not been audited or independently verified.…”
Section: Discussionmentioning
confidence: 99%
“…In our patient, the findings were normal which is in accordance with a previous study. 16 Malignancies are another challenge in this patient population and several patients' contract posttransplant lymphoproliferative disorders. 5 In a recent study, the detection rate of small-bowel tumors was superior with VCE compared with other methods.…”
Section: Discussionmentioning
confidence: 99%